Article Details
Retrieved on: 2021-08-05 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Strongbridge Biopharma (SBBP) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.10.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here